Tag: GSV
FDA approves IDE for pivotal study of high-intensity focused ultrasound platform
The Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application for the VEINRESET multicenter pivotal study that will evaluate Sonovein...
No long-term advantage of endovenous laser ablation over great saphenous vein...
Ten-year follow-up of a randomised controlled trial (RCT) has shown no clear long-term advantage of endovenous laser ablation (EVLA) with a 980nm wavelength and...